Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Journal articles
, 2026, 'Neurodegeneration as an evolutionary trade-off: a biological constraint–aware therapeutic perspective', Molecular Neurodegeneration, 21, http://dx.doi.org/10.1186/s13024-026-00958-w
, 2026, 'Corrigendum to “The effects of alterations in conditioning stimulus intensity on short interval intracortical inhibition” [Brain Res. 1273 (2009) 39–47]', Brain Research, 1889, http://dx.doi.org/10.1016/j.brainres.2026.150475
, 2026, 'Cortical changes in amyotrophic lateral sclerosis: comparing biomarkers of glymphatic flow and cortical excitability', Clinical Neurophysiology, 190, http://dx.doi.org/10.1016/j.clinph.2026.2111949
, 2026, 'Gold Coast criteria for ALS diagnosis: individual participant data meta-analysis', Journal of Neurology, 273, http://dx.doi.org/10.1007/s00415-026-14046-y
, 2026, 'Muscle Ultrasound Is a Sensitive Outcome Measure in ALS', Muscle and Nerve, 74, pp. 590 - 599, http://dx.doi.org/10.1002/mus.70317
, 2026, 'Systemic dysregulation of apolipoproteins in amyotrophic lateral sclerosis serum', FEBS Open Bio, 16, pp. 1550 - 1562, http://dx.doi.org/10.1002/2211-5463.70232
, 2026, 'The Dynamics of Neurofilament Light Chain in Spinal Muscular Atrophy', Annals of Neurology, 100, pp. 109 - 122, http://dx.doi.org/10.1002/ana.78207
, 2026, 'Measuring Disease Activity During Maintenance Therapy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (P7-9.003)', Neurology, 106, http://dx.doi.org/10.1212/wnl.0000000000217482
, 2026, 'Application of a Clinical-Electrophysiological Model for Identifying Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Australian Cohort', Journal of the Peripheral Nervous System, 31, http://dx.doi.org/10.1111/jns.70125
, 2026, 'Strategic Amyotrophic Lateral Sclerosis Australia–Systems Genomics Consortium (SALSA-SGC): cohort profile', BMJ Open, 16, http://dx.doi.org/10.1136/bmjopen-2025-110906
, 2026, 'Utility of Far-Field Potentials as a Biomarker of Neurodegeneration in Spinal Muscular Atrophy', Muscle and Nerve, 73, pp. 1089 - 1095, http://dx.doi.org/10.1002/mus.70231
, 2026, 'Corrigendum to “Cortical hyperexcitability drives dying forward amyotrophic lateral sclerosis symptoms and pathology in mice”[Prog. Neurobiol. 252 (2025) 102809]', Progress in Neurobiology, 260, http://dx.doi.org/10.1016/j.pneurobio.2026.102910
, 2026, 'Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis', Nature Genetics, 58, pp. 717 - 725, http://dx.doi.org/10.1038/s41588-026-02535-9
, 2026, 'The Use of Durable Medical Equipment in COURAGE-ALS, a Phase 3, Multicentre, Randomized Clinical Trial for ALS', Muscle and Nerve, 73, pp. 608 - 614, http://dx.doi.org/10.1002/mus.70150
, 2026, 'Genetic characterisation of ATXN2 in Australian amyotrophic lateral sclerosis', Brain Disorders, 21, http://dx.doi.org/10.1016/j.dscb.2025.100301
, 2026, 'Characterising the motif composition and allele length distribution of ZFHX3 GGC repeat expansions in amyotrophic lateral sclerosis', Journal of Human Genetics, http://dx.doi.org/10.1038/s10038-026-01513-7
, 2026, 'Cortical excitability stratifies neurochemical profiles in amyotrophic lateral sclerosis', Brain Communications, 8, http://dx.doi.org/10.1093/braincomms/fcag292
, 2026, 'Integration of Serum Neurofilament Light Chain and Cortical Dysfunction Improves Diagnostic Accuracy in ALS', Annals of Clinical and Translational Neurology, http://dx.doi.org/10.1002/acn3.70454
, 2026, 'Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy', Nature Neuroscience, 29, pp. 40 - 52, http://dx.doi.org/10.1038/s41593-025-02118-7
, 2026, 'The World Federation of Neurology Specialty Group in ALS/MND: toward strategic partnership and new frontiers', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 27, pp. 501 - 503, http://dx.doi.org/10.1080/21678421.2026.2663915
, 2026, 'Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paper', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 27, pp. 493 - 500, http://dx.doi.org/10.1080/21678421.2025.2593308
, 2026, 'Correction to “Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions”', Annals of Neurology, 99, pp. 288 - 288, http://dx.doi.org/10.1002/ana.78107
, 2026, 'Corrigendum to “Exploring the Evolution of Cortical Excitability Following Acute Stroke”', Neurorehabilitation and Neural Repair, 40, pp. 598 - 598, http://dx.doi.org/10.1177/15459683261447055
, 2025, 'An Annotated Multi-Site and Multi-Contrast Magnetic Resonance Imaging Dataset for the study of the Human Tongue Musculature', Scientific Data, 12, http://dx.doi.org/10.1038/s41597-025-05092-8
, 2025, 'Longitudinal assessment of cortical motor function in amyotrophic lateral sclerosis', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-01570-6
, 2025, 'Multi-region brain transcriptomic analysis of amyotrophic lateral sclerosis reveals widespread RNA alterations and substantial cerebellum involvement', Molecular Neurodegeneration, 20, http://dx.doi.org/10.1186/s13024-025-00820-5
, 2025, 'Polysomnographic titration of non-invasive ventilation in motor neurone disease (3TLA): protocol for a process evaluation of a clinical trial', Trials, 26, http://dx.doi.org/10.1186/s13063-025-08784-z
, 2025, 'Polysomnographic titration of non-invasive ventilation in motor neurone disease (3TLA): study protocol for a randomised controlled trial', Trials, 26, http://dx.doi.org/10.1186/s13063-024-08464-4
, 2025, 'The nature of fatigue in amyotrophic lateral sclerosis: a systematic review and meta-analysis', Acta Neurologica Belgica, 125, pp. 1535 - 1544, http://dx.doi.org/10.1007/s13760-025-02890-0
, 2025, 'Using cluster analysis to identify the health literacy strengths and challenges of people living with motor neurone disease in Australia', BMC Health Services Research, 25, http://dx.doi.org/10.1186/s12913-025-12998-x
, 2025, 'Susceptibility to visual hallucinations in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum: The role of dysfunctional attentional networks', Cortex, 192, pp. 213 - 226, http://dx.doi.org/10.1016/j.cortex.2025.08.014
, 2025, 'The FindMNDBiomarker Program: Protein Changes in Motor Neuron Disease/Amyotrophic Lateral Sclerosis Postmortem Tissue and Biofluids', Annals of Neurology, 98, pp. 788 - 800, http://dx.doi.org/10.1002/ana.27300
, 2025, 'Mantle cell lymphoma presenting as bilateral upper eyelid entropion', Orbit, 44, pp. 680 - 680, http://dx.doi.org/10.1080/01676830.2022.2025858
, 2025, 'Cortical hyperexcitability drives dying forward amyotrophic lateral sclerosis symptoms and pathology in mice', Progress in Neurobiology, 252, http://dx.doi.org/10.1016/j.pneurobio.2025.102809
, 2025, 'Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis', Lancet Regional Health Western Pacific, 62, http://dx.doi.org/10.1016/j.lanwpc.2025.101684
, 2025, 'Segmentation of the human tongue musculature using MRI: Field guide and validation in motor neuron disease', Computers in Biology and Medicine, 196, http://dx.doi.org/10.1016/j.compbiomed.2025.110824
, 2025, 'Diagnostic utility of threshold tracking TMS paradigms in early amyotrophic lateral sclerosis', Clinical Neurophysiology, 174, pp. 105 - 113, http://dx.doi.org/10.1016/j.clinph.2025.03.044
, 2025, 'Utility of Cortical Inhibitory and Facilitatory Neuronal Circuits in Amyotrophic Lateral Sclerosis Diagnosis', European Journal of Neurology, 32, http://dx.doi.org/10.1111/ene.70203
, 2025, 'Application of a Clinical-electrophysiologic Model for Distinguishing Chronic Inflammatory Demyelinating Neuropathy (CIDP) in an Australian Cohort (P10-11.033)', Neurology, 104, http://dx.doi.org/10.1212/wnl.0000000000212523
, 2025, 'Amyotrophic lateral sclerosis represents corticomotoneuronal system failure', Muscle and Nerve, 71, pp. 499 - 511, http://dx.doi.org/10.1002/mus.28290
, 2025, 'Direct interrogation of cortical interneuron circuits in amyotrophic lateral sclerosis', Brain, 148, pp. 1169 - 1179, http://dx.doi.org/10.1093/brain/awae317
, 2025, 'Utility of the Gold Coast criteria for amyotrophic lateral sclerosis: Experience with fast progressors', Journal of the Neurological Sciences, 470, http://dx.doi.org/10.1016/j.jns.2025.123417
, 2025, 'Quantifying neurodegeneration within subdivisions of core motor pathways in amyotrophic lateral sclerosis using diffusion MRI', Journal of Neurology, 272, http://dx.doi.org/10.1007/s00415-025-12920-9
, 2025, 'Recent developments in consensus diagnostic criteria for amyotrophic lateral sclerosis', Eneurologicalsci, 38, http://dx.doi.org/10.1016/j.ensci.2025.100559
, 2025, 'Developing a nationwide registry of UK veterans seeking help from sector charities—a machine learning approach to stratification', European Journal of Public Health, 35, pp. 5 - 10, http://dx.doi.org/10.1093/eurpub/ckae141
, 2025, 'Muscle ultrasound aids diagnosis in amyotrophic lateral sclerosis', Clinical Neurophysiology, 170, pp. 234 - 243, http://dx.doi.org/10.1016/j.clinph.2024.11.008
, 2025, 'Neurophysiological assessment of cortical motor function: A direct comparison of methodologies', Clinical Neurophysiology, 170, pp. 14 - 21, http://dx.doi.org/10.1016/j.clinph.2024.12.001
, 2025, 'Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale', Clinical and Experimental Rheumatology, 43, pp. 316 - 325, http://dx.doi.org/10.55563/clinexprheumatol/zvffa0
, 2025, 'The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations', Brain Sciences, 15, http://dx.doi.org/10.3390/brainsci15020195
, 2025, 'Transforming amyotrophic lateral sclerosis into a liveable disease', Lancet Neurology, 24, pp. 100 - 101, http://dx.doi.org/10.1016/S1474-4422(24)00523-4